NIVADIL Side Effects

5293087-8 | Dizziness, Hypoacusis, Pyrexia, Sudden Hearing Loss, Vomiting
on Mar 30, 2007 Male patient from JAPAN , 67 years of age, was diagnosed with hypertension, hypersensitivity, insomnia, gastric ulcer and was treated with Nivadil (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hypoacusis, pyrexia, sudden hearing loss, vomiting. Nivadil dosage: . During the same period patient was treated with AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), AMOBAN (View Amoban Review and Amoban Label ), GASTER D (View Gaster D Review and Gaster D Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), TERNELIN (View Ternelin Review and Ternelin Label ), CALBLOCK (View Calblock Review and Calblock Label ). Patient was hospitalized.

5292929-X | Dizziness, Hypoacusis, Pyrexia, Sudden Hearing Loss, Vomiting
Patient was taking Nivadil (View Usage). Patient had the following side effects: dizziness (What is dizziness?), hypoacusis, pyrexia, sudden hearing loss, vomiting on Mar 30, 2007 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with hypertension, hypersensitivity, insomnia, gastric ulcer and. Nivadil dosage: . During the same period patient was treated with AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), AMOBAN (View Amoban Review and Amoban Label ), GASTER D (View Gaster D Review and Gaster D Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), TERNELIN (View Ternelin Review and Ternelin Label ), CALBLOCK (View Calblock Review and Calblock Label ). Patient was hospitalized.

5098377-X | Anaemia, Anorexia, Blood Lactate Dehydrogenase Increased, Haematocrit Decreased, Haemoglobin Decreased, Malaise, Mean Cell Volume Abnormal, Pancytopenia, Platelet Count Decreased
Adverse event was reported on Jul 11, 2006 by a Male patient taking Nivadil (View Usage) (Dosage: 8 Mg/day) was diagnosed with hypertension, cerebral infarction, benign prostatic hyperplasia, nail tinea and. Location: JAPAN , 70 years of age, weighting 127.9 lb, After Nivadil was administered, patient had the following side effects: anaemia, anorexia, blood lactate dehydrogenase increased, haematocrit decreased, haemoglobin decreased, malaise, mean cell volume abnormal, pancytopenia, platelet count decreased. During the same period patient was treated with PANALDINE (200 Mg/day) (View Panaldine Review and Panaldine Label ), HARNAL (0.2 Mg/day) (View Harnal Review and Harnal Label ), LAMISIL (125 Mg/d) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

5098233-7 | Anaemia, Anorexia, Blood Lactate Dehydrogenase Increased, Haematocrit Decreased, Haemoglobin Decreased, Malaise, Mean Cell Volume Abnormal, Pancytopenia, Platelet Count Decreased
on Jul 11, 2006 Male patient from JAPAN , 70 years of age, weighting 127.9 lb, was diagnosed with hypertension, cerebral infarction, benign prostatic hyperplasia, nail tinea and was treated with Nivadil (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, anorexia, blood lactate dehydrogenase increased, haematocrit decreased, haemoglobin decreased, malaise, mean cell volume abnormal, pancytopenia, platelet count decreased. Nivadil dosage: 8 Mg/day. During the same period patient was treated with PANALDINE (200 Mg/day) (View Panaldine Review and Panaldine Label ), HARNAL (0.2 Mg/day) (View Harnal Review and Harnal Label ), LAMISIL (125 Mg/d) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.


5078780-4 | Anaemia, Anorexia, Blood Lactate Dehydrogenase Increased, Haematocrit Decreased, Haemoglobin Decreased, Malaise, Mean Cell Volume Abnormal, Pancytopenia, Platelet Count Decreased
on Jul 11, 2006 Male patient from JAPAN , 70 years of age, weighting 127.9 lb, was diagnosed with hypertension, cerebral infarction, benign prostatic hyperplasia, nail tinea and was treated with Nivadil (View Usage). Patient had the following side effects: anaemia, anorexia, blood lactate dehydrogenase increased, haematocrit decreased, haemoglobin decreased, malaise, mean cell volume abnormal, pancytopenia, platelet count decreased. Nivadil dosage: 8 Mg/day. During the same period patient was treated with PANALDINE (200 Mg/day) (View Panaldine Review and Panaldine Label ), HARNAL (0.2 Mg/day) (View Harnal Review and Harnal Label ), LAMISIL (125 Mg/d) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

5054636-8 | Anorexia, Blood Lactate Dehydrogenase Increased, Haematocrit Decreased, Haemoglobin Decreased, Malaise, Mean Cell Volume Abnormal, Pancytopenia, Platelet Count Decreased, Red Blood Cell Count Decreased
Patient was taking Nivadil (View Usage). After Nivadil was administered, patient had the following side effects: anorexia, blood lactate dehydrogenase increased, haematocrit decreased, haemoglobin decreased, malaise, mean cell volume abnormal, pancytopenia, platelet count decreased, red blood cell count decreased on Jul 11, 2006 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with nail tinea and. Nivadil dosage: . During the same period patient was treated with PANALDINE (View Panaldine Review and Panaldine Label ), HARNAL (View Harnal Review and Harnal Label ), LAMISIL (125 Mg/d) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

4899933-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bile Duct Cancer, Biliary Neoplasm, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
Adverse event was reported on Aug 22, 2005 by a Female patient taking Nivadil (View Usage) (Dosage: 8 Mg/d) was diagnosed with essential hypertension, nail tinea and. Location: JAPAN , 76 years of age, weighting 103.6 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct cancer, biliary neoplasm, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal. During the same period patient was treated with TENORMIN (5 Mg/d) (View Tenormin Review and Tenormin Label ), APLACE (300 Mg/d) (View Aplace Review and Aplace Label ), KARIKUROMONE (150 Mg/d) (View Karikuromone Review and Karikuromone Label ), LAMISIL (125 Mg, Qd) (View Lamisil Review and Lamisil Label ), SALUMOSIN (15 Mg/d) (View Salumosin Review and Salumosin Label ).

4832813-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Hepatic Neoplasm Malignant, Jaundice
on Aug 22, 2005 Female patient from JAPAN , 76 years of age, weighting 103.6 lb, was diagnosed with essential hypertension, nail tinea and was treated with Nivadil (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, hepatic neoplasm malignant, jaundice (What is jaundice?). Nivadil dosage: 8 Mg/d. During the same period patient was treated with TENORMIN (5 Mg/d) (View Tenormin Review and Tenormin Label ), APLACE (300 Mg/d) (View Aplace Review and Aplace Label ), KARIKUROMONE (150 Mg/d) (View Karikuromone Review and Karikuromone Label ), LAMISIL (125 Mg, Qd) (View Lamisil Review and Lamisil Label ), SALUMOSIN (15 Mg/d) (View Salumosin Review and Salumosin Label ).

4821525-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bile Duct Cancer, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Hepatic Neoplasm Malignant
on Aug 22, 2005 Female patient from JAPAN , 76 years of age, weighting 103.6 lb, was diagnosed with essential hypertension, nail tinea and was treated with Nivadil (View Usage). After Nivadil was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct cancer, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, hepatic neoplasm malignant. Nivadil dosage: 4 Mg/d. During the same period patient was treated with TENORMIN (5 Mg/d) (View Tenormin Review and Tenormin Label ), APLACE (View Aplace Review and Aplace Label ), KARIKUROMONE (View Karikuromone Review and Karikuromone Label ), LAMISIL (125 Mg, Qd) (View Lamisil Review and Lamisil Label ).

4820489-3 | Alanine Aminotransferase Increased, Anal Cancer, Aspartate Aminotransferase Increased, Bile Duct Cancer, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
Patient was taking Nivadil (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anal cancer (What is anal cancer?), aspartate aminotransferase increased, bile duct cancer, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal on Aug 22, 2005 from JAPAN Additional patient health information: Female patient , 76 years of age, weighting 103.6 lb, was diagnosed with essential hypertension, nail tinea and. Nivadil dosage: 4 Mg/d. During the same period patient was treated with TENORMIN (5 Mg/d) (View Tenormin Review and Tenormin Label ), APLACE (View Aplace Review and Aplace Label ), KARIKUROMONE (View Karikuromone Review and Karikuromone Label ), LAMISIL (125 Mg, Qd) (View Lamisil Review and Lamisil Label ).

4780073-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bile Duct Cancer, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
Adverse event was reported on Aug 22, 2005 by a Female patient taking Nivadil (View Usage) (Dosage: 4 Mg/d) was diagnosed with nail tinea and. Location: JAPAN , 77 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct cancer, gamma-glutamyltransferase increased, hepatic function abnormal. During the same period patient was treated with TENORMIN (5 Mg/d) (View Tenormin Review and Tenormin Label ), APLACE (View Aplace Review and Aplace Label ), KARIKUROMONE (View Karikuromone Review and Karikuromone Label ), LAMISIL (View Lamisil Review and Lamisil Label ).

4598692-X | Cerebral Infarction, Cerebral Thrombosis, Depressed Level Of Consciousness, Dysarthria, Facial Palsy
on Jan 15, 2004 Female patient from , 83 years of age, weighting 132.3 lb, was diagnosed with hypertension, angina pectoris, hypercholesterolaemia and was treated with Nivadil (View Usage). After Nivadil was administered, patient had the following side effects: cerebral infarction, cerebral thrombosis, depressed level of consciousness, dysarthria, facial palsy. Nivadil dosage: Unk, Unk. During the same period patient was treated with BUFFERIN (81mg Daily Dose) (View Bufferin Review and Bufferin Label ), EPADEL (1.2g Daily Dose) (View Epadel Review and Epadel Label ), DIOVAN (Unk, Unk) (View Diovan Review and Diovan Label ). Patient was hospitalized.

4588150-0 | Cerebral Infarction, Cerebral Thrombosis, Depressed Level Of Consciousness, Dysarthria, Facial Palsy
on Jan 15, 2004 Female patient from , 83 years of age, weighting 132.3 lb, was diagnosed with hypertension, angina pectoris, hypercholesterolaemia and was treated with Nivadil (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, cerebral thrombosis, depressed level of consciousness, dysarthria, facial palsy. Nivadil dosage: Unk, Unk. During the same period patient was treated with BUFFERIN (81mg Daily Dose) (View Bufferin Review and Bufferin Label ), EPADEL (1.2g Daily Dose) (View Epadel Review and Epadel Label ), DIOVAN (Unk, Unk) (View Diovan Review and Diovan Label ). Patient was hospitalized.